Results 231 to 240 of about 1,127,331 (318)
Bone Mineral Density and Bone Quality Trends in a Child on Steroid Therapy Who Developed a Vertebral Fracture: A Case Report. [PDF]
Aoyagi J+4 more
europepmc +1 more source
Observations on the Phosphatase Content of Blood and Bone Marrow Cells in Normal and Pathologic Hemopoiesis [PDF]
William Kerppola
openalex +1 more source
Canopy FGF signaling regulator 2 (CNPY2) which is contributed to ERS is upregulated in the renal tubules of patients with diabetic nephropathy (DN). Mechanistically, CNPY2 may regulate ferroptosis and MAM integrity in renal tubular epithelial cells through PERK/ATF4/CHAC1 pathway, thereby promoting the progression of DN.
Jingfang Chen+9 more
wiley +1 more source
HISTOCHEMICAL DEMONSTRATION OF ACID PHOSPHATASE BY AN IMPROVED AZO-DYE METHOD
Jennifer Burton
openalex +1 more source
THE ABOLITION INFLUENCE OF HORMONES UPON PHOSPHATASE CONTENT OF RAT FEMURSII. EFFECTS OF SEX HORMONES, THYROXIN AND THYMUS EXTRACT1 [PDF]
H. L. Williams, E. M. Watson
openalex +1 more source
S‐ketamine binds directly to SIRT2, facilitating its interaction with NF‐κB p65. This interaction reduces the acetylation of NF‐κB p65 and inhibits its activation, thereby exerting anti‐inflammatory and antidepressant effects. Created by BioRender.
Cong Lin+7 more
wiley +1 more source
PHLPP2 is a pseudophosphatase that lost activity in the metazoan ancestor. [PDF]
Husremović T+24 more
europepmc +1 more source
Gelsolin's Protective Role in MASH through F‐Actin Regulation and P53 Degradation
Gelsolin (GSN) maintains liver metabolic homeostasis by promoting MDM2‐mediated P53 degradation and inhibiting F‐actin/Yes‐associated protein (YAP) overactivation. Loss of GSN impairs P53 degradation, increases lipid deposition, and enhances YAP‐driven fibrosis and inflammation in metabolic‐associated steatohepatitis.
Yiwei Lu+9 more
wiley +1 more source
Age, inflammation, alkaline phosphatase, and coronary artery calcification in firefighters. [PDF]
Li M+9 more
europepmc +1 more source